Clinical Trial Update: Effects of N-acetylcysteine on Muscle Fatigue in Hemodialysis [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating whether N-acetylcysteine can reduce muscle fatigue in patients with end-stage renal disease undergoing hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: End-Stage Renal Disease, Dialysis | Phase 1 | Status: COMPLETED